Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biophysical Characterization of the Leukemic Bone Marrow Vasculature Reveals Benefits of Neoadjuvant Low-Dose Radiation Therapy

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.037Source: DataRank Database

Biophysical Characterization of the Leukemic Bone Marrow Vasculature Reveals Benefits of Neoadjuvant Low-Dose Radiation Therapy is a research paper published in International Journal of Radiation Oncology*Biology*Physics (2020). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.45)OA: hybridTopics (44)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Bijender Kumar ORCID,Darren Zuro,Jonathan D. Raybuck ORCID,Srideshikan Sargur Madabushi ORCID,Paresh Vishwasrao ORCID

Live enrichment

PubMed:32841681 PMC:PMC7736317 OpenAlex:https://openalex.org/W3080111972

NCI NIH HHS

Grant: R01 CA154491

NCI NIH HHS

Grant: P30 CA033572

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

National Institutes of Health

Grant: 2R01CA154491-07A1

Conformal Total Body and Marrow Irradiation for Leukemia

National Institutes of Health

FWCI

0.45

Citation Percentile

0.6%

Citation Trend

2021

2022

2024

2025

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.ijrobp.2020.08.037

publisherhttps://doi.org/10.1016/j.ijrobp.2020.08.037

publisherhttps://api.elsevier.com/content/article/PII:S0360301620341328?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0360301620341328?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32841681

Fields of Study

Angiogenesis and VEGF in CancerAdvanced Fluorescence Microscopy TechniquesMRI in cancer diagnosis0301 basic medicine0303 health sciences03 medical and health sciences0302 clinical medicine

MeSH Terms

AnimalsBone MarrowNeovascularization, PathologicRadiation DosageRadiotherapy DosageNeoadjuvant TherapyCell Line, TumorMicePrecursor Cell Lymphoblastic Leukemia-LymphomaTumor Microenvironment

Keywords

MedicineBone marrowRadiation therapyNilotinibChemotherapyAngiogenesisPerfusionLeukemiaDaunorubicinCancer researchVascular permeabilityDrug deliveryIn vivoPathologyInternal medicineMyeloid leukemiaImatinibNeovascularization, PathologicRadiotherapy DosagePrecursor Cell Lymphoblastic Leukemia-LymphomaRadiation DosageArticleNeoadjuvant TherapyMiceCell Line, TumorTumor MicroenvironmentAnimals

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Biophysical Characterization of the Leukemic Bone Marrow Vasculature Reveals Benefits of Neoadjuvant Low-Dose Radiation Therapy

FAIR Checklist

Authors (11)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)